Mondaq All Regions: Food, Drugs, Healthcare, Life Sciences > Life Sciences, Biotechnology & Nanotechnology
Arnold & Porter
Viridis's use of the BOSWELAN mark during the clinical trial was purely internal in nature.
Singh & Associates
On July 19, 2019, Delhi High Court granted permanent injunction against Lee Pharmaceuticals, restraining it from infringing the copyright of Mankind Pharma Ltd.
AZB & Partners
Any business interested in establishing a business in India is required to first ascertain whether the business is to operate as a foreign entity having a presence in India
McDermott Will & Emery
The FDA recently released six guidance documents as part of the agency's continued focus on updating the regulatory stance on software as a medical device and other digital health products
Butler Snow LLP
If you have ever read The Jungle Book, a collection of stories by Rudyard Kipling, Rikki-Tikki-Tavi should sound familiar.
Foley Hoag LLP
On September 18, 2019, the Department of Justice announced a $21.36 million settlement to resolve a False Claims Act ("FCA")
Duane Morris LLP
With the advancements in technology and the advent of artificial intelligence, the medical device industry is flourishing.
Duane Morris LLP
The FCA creates liability for persons or entities found to have knowingly submitted false claims to the government or having caused others to do so.
Wilson Sonsini Goodrich & Rosati
The U.S. Food and Drug Administration (FDA) continues advancing regulatory policies tailored to the digital health community. On September 26, 2019
Hogan Lovells
On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released a series of guidance documents addressing the agency's ...
Hogan Lovells
On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released the draft guidance entitled "Clinical Decision Support Software" (CDS guidance), ...
Duane Morris LLP
Genetic testing and telemedicine targeting senior citizens and individuals with disabilities have been the subject of growing government scrutiny.
Foley Hoag LLP
On September 18, 2019, the Department of Justice announced a $21.36 million settlement to resolve a False Claims Act ("FCA")
Reed Smith
Today's guest post is by Reed Smith‘s Jenn Eppensteiner. In it she discusses a recurring theme on the Blog – claimed product "defects" arising from nothing more than the failure of an implanted ...
Reed Smith
The defense has done a good job of preventing class certification of drug and device mass torts. Individual issues of usage, causation, reliance, injury, etc. predominate over alleged common issues.
Shook, Hardy & Bacon L.L.P.
Shook Partners Hildy Sastre and Jennise Stubbs, along with Of Counsel Sonali Gunawardhana, have co-authored the USA section of Chambers and Partners'
Ropes & Gray LLP
In this recap of our September presentation, which includes video and an accompanying transcript, panelists – life sciences regulatory & compliance partner Kellie Combs,...
BakerHostetler
Acting FDA Commissioner Discusses Food Safety Modernization Act (FSMA) Progress – Acting Commissioner Sharpless announced the Food ...
Sheppard Mullin Richter & Hampton
On September 26, 2019, the US Food and Drug Administration (FDA) published six guidance documents clarifying its scope of authority and enforcement...
Shook, Hardy & Bacon L.L.P.
Shook Partner Chris Kaufman and Associate Torrey Peterson have co-authored an article for DRI's For the Defense on "Exposing Meritless Claims in Drug and Medical Device Product Liability MDLs."
Latest Video
Most Popular Recent Articles
Cyril Amarchand Mangaldas
Gujarat has been the flag bearer of India's pharmaceutical industry since the establishment of the country's second oldest drug company
Oblon, McClelland, Maier & Neustadt, L.L.P
Design patents are very different from utility patents in that design patents only protect the ornamental features of an invention. In contrast to utility patents, the design is defined
Reed Smith
Donald Rumsfeld once justified attacking Iraq without firm evidence that his target possessed the ultimately apocryphal
Sheppard Mullin Richter & Hampton
On September 26, 2019, the US Food and Drug Administration (FDA) published six guidance documents clarifying its scope of authority and enforcement...
Shook, Hardy & Bacon L.L.P.
Plaintiffs' attorneys are spending billions of dollars saturating the airwaves with advertisements that target prescription drugs and medical devices for lawsuits.
Marshall, Gerstein & Borun LLP
What is synthetic biology? At a fundamental level, synthetic biology is an interdisciplinary area applying engineering principles to biology ...
S.S. Rana & Co. Advocates
A counterfeit product is one that is intended to deceive consumers into buying a fake or fraudulent product by misappropriating someone else's registered trademark or one that is deceptively similar
Arnold & Porter
Viridis's use of the BOSWELAN mark during the clinical trial was purely internal in nature.
Morrison & Foerster LLP
We are pleased to announce the launch of the MoFo NDCal IP Resource Center. This complimentary resource is available to the public and provides insights on the judges
Oblon, McClelland, Maier & Neustadt, L.L.P
The majority expressed caution about the breadth of its holding, in particular about concerns that the holding could harm the nascent field of personalized medicine.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter